These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

607 related items for PubMed ID: 17062323

  • 1. Psychotropic use in community residential care facilities: A prospective cohort study.
    Lakey SL, Gray SL, Sales AE, Sullivan J, Hedrick SC.
    Am J Geriatr Pharmacother; 2006 Sep; 4(3):227-35. PubMed ID: 17062323
    [Abstract] [Full Text] [Related]

  • 2. Polypharmacy in nursing home residents in the United States: results of the 2004 National Nursing Home Survey.
    Dwyer LL, Han B, Woodwell DA, Rechtsteiner EA.
    Am J Geriatr Pharmacother; 2010 Feb; 8(1):63-72. PubMed ID: 20226393
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Prevalence of psychotropic drug use in nursing homes for the aged in Quebec and in the French-speaking area of Switzerland.
    Gobert M, D'hoore W.
    Int J Geriatr Psychiatry; 2005 Aug; 20(8):712-21. PubMed ID: 16035123
    [Abstract] [Full Text] [Related]

  • 5. Nursing working conditions in relation to restraint practices in long-term care units.
    Pekkarinen L, Elovainio M, Sinervo T, Finne-Soveri H, Noro A.
    Med Care; 2006 Dec; 44(12):1114-20. PubMed ID: 17122716
    [Abstract] [Full Text] [Related]

  • 6. Quality of medication records and use of pharmacy resources in community residential care facilities.
    Gray SL, Odegard PS, Sales AE, Young HM, Sullivan JH, Hedrick SC.
    Ann Pharmacother; 2006 May; 40(5):894-9. PubMed ID: 16638918
    [Abstract] [Full Text] [Related]

  • 7. A national study of prescribed drugs in institutions and community residential facilities for mentally retarded people.
    Hill BK, Balow EA, Bruininks RH.
    Psychopharmacol Bull; 1985 May; 21(2):279-84. PubMed ID: 4001292
    [Abstract] [Full Text] [Related]

  • 8. Determinants of antidepressant medication prescribing in elderly residents of aged care homes in Australia: a retrospective study.
    Nishtala PS, McLachlan AJ, Bell JS, Chen TF.
    Am J Geriatr Pharmacother; 2009 Aug; 7(4):210-9. PubMed ID: 19766953
    [Abstract] [Full Text] [Related]

  • 9. Reducing antipsychotic drug use in nursing homes. A controlled trial of provider education.
    Ray WA, Taylor JA, Meador KG, Lichtenstein MJ, Griffin MR, Fought R, Adams ML, Blazer DG.
    Arch Intern Med; 1993 Mar 22; 153(6):713-21. PubMed ID: 8447709
    [Abstract] [Full Text] [Related]

  • 10. The course of psychiatric and behavioral symptoms and the use of psychotropic medication in patients with dementia in Norwegian nursing homes--a 12-month follow-up study.
    Selbaek G, Kirkevold Ø, Engedal K.
    Am J Geriatr Psychiatry; 2008 Jul 22; 16(7):528-36. PubMed ID: 18591573
    [Abstract] [Full Text] [Related]

  • 11. Appropriate use of psychotropic drugs in nursing homes.
    Gurvich T, Cunningham JA.
    Am Fam Physician; 2000 Mar 01; 61(5):1437-46. PubMed ID: 10735348
    [Abstract] [Full Text] [Related]

  • 12. Analysis of the North Carolina long-term care polypharmacy initiative: a multiple-cohort approach using propensity-score matching for both evaluation and targeting.
    Trygstad TK, Christensen DB, Wegner SE, Sullivan R, Garmise JM.
    Clin Ther; 2009 Sep 01; 31(9):2018-37. PubMed ID: 19843492
    [Abstract] [Full Text] [Related]

  • 13. Use of psychotropic medicines in residential care facilities for older people in Hawke's Bay, New Zealand.
    Tucker M, Hosford I.
    N Z Med J; 2008 May 23; 121(1274):18-25. PubMed ID: 18535643
    [Abstract] [Full Text] [Related]

  • 14. Psychotropic medication of mentally retarded residents in community long-term care facilities.
    Buck JA, Sprague RL.
    Am J Ment Retard; 1989 May 23; 93(6):618-23. PubMed ID: 2566316
    [Abstract] [Full Text] [Related]

  • 15. Satisfaction with care among community residential care residents.
    Curtis MP, Sales AE, Sullivan JH, Gray SL, Hedrick SC.
    J Aging Health; 2005 Feb 23; 17(1):3-27. PubMed ID: 15601781
    [Abstract] [Full Text] [Related]

  • 16. Psychotropic medication use and association with physical and psychosocial outcomes in nursing home residents.
    Galik E, Resnick B.
    J Psychiatr Ment Health Nurs; 2013 Apr 23; 20(3):244-52. PubMed ID: 22500725
    [Abstract] [Full Text] [Related]

  • 17. An outreach geriatric medication advisory service in residential aged care: a randomised controlled trial of case conferencing.
    Crotty M, Halbert J, Rowett D, Giles L, Birks R, Williams H, Whitehead C.
    Age Ageing; 2004 Nov 23; 33(6):612-7. PubMed ID: 15385274
    [Abstract] [Full Text] [Related]

  • 18. A ten-year review of the effect of OBRA-87 on psychotropic prescribing practices in an academic nursing home.
    Lantz MS, Giambanco V, Buchalter EN.
    Psychiatr Serv; 1996 Sep 23; 47(9):951-5. PubMed ID: 8875659
    [Abstract] [Full Text] [Related]

  • 19. Factors affecting choice of community residential care setting.
    Sales AE, Hedrick SC, Sullivan J, Gray SL, Curtis M, Tornatore J.
    J Aging Health; 2005 Apr 23; 17(2):190-206. PubMed ID: 15750051
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of nationally mandated drug use reviews to improve patient safety in nursing homes: a natural experiment.
    Briesacher B, Limcangco R, Simoni-Wastila L, Doshi J, Gurwitz J.
    J Am Geriatr Soc; 2005 Jun 23; 53(6):991-6. PubMed ID: 15935022
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.